RESITUNE

Serial Number 77767301
606

Registration Progress

Application Filed
Jun 24, 2009
Under Examination
Feb 2, 2010
Approved for Publication
Oct 21, 2009
Published for Opposition
Nov 10, 2009
Registered

Trademark Image

RESITUNE

Basic Information

Serial Number
77767301
Filing Date
June 24, 2009
Published for Opposition
November 10, 2009
Abandonment Date
March 4, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 4, 2013
Classes
005

Rights Holder

Agouron Pharmaceuticals, Inc.

03
Address
10777 Science Center Drive
San Diego, CA 92121

Ownership History

Agouron Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Agouron Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Sudipta Rao

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Mar 4, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 4, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Aug 8, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Aug 7, 2012 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 31, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 31, 2012 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 8, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Feb 7, 2012 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 31, 2012 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 31, 2012 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 31, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 31, 2012 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 4, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Aug 3, 2011 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 2, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 2, 2011 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 16, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Feb 15, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 15, 2011 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 26, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 26, 2011 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 29, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Jul 27, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 27, 2010 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 27, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 2, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 10, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 21, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Oct 6, 2009 ALIE A ASSIGNED TO LIE Loading...
Oct 6, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 22, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 22, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 27, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005